Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00051584
Status:
TERMINATED
Last Update Posted:
2011-10-24
First Post:
2003-01-13
Brief Title:
SafetyEfficacy Study of SGN-15 Antibody-Drug Conjugate Combined With Gemcitabine in Patients With Ovarian Cancer
Sponsor:
Seagen Inc
Organization:
Seagen Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Ovarian Neoplasms |
Keywords: